Peter J. Tummino

12.4k total citations · 1 hit paper
76 papers, 4.8k citations indexed

About

Peter J. Tummino is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Peter J. Tummino has authored 76 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 17 papers in Organic Chemistry and 16 papers in Infectious Diseases. Recurrent topics in Peter J. Tummino's work include HIV/AIDS drug development and treatment (16 papers), Epigenetics and DNA Methylation (13 papers) and HIV Research and Treatment (11 papers). Peter J. Tummino is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), Epigenetics and DNA Methylation (13 papers) and HIV Research and Treatment (11 papers). Peter J. Tummino collaborates with scholars based in United States, United Kingdom and Netherlands. Peter J. Tummino's co-authors include Robert A. Copeland, James M. Gavin, Chad Vickers, Paul Hales, Michael A. Patane, Virendar K. Kaushik, Thomas F. Parsons, Andrew J. Nichols, Jin Tang and F. Hsieh and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Peter J. Tummino

74 papers receiving 4.7k citations

Hit Papers

Hydrolysis of Biological Peptides by Human Angiotensin-co... 2002 2026 2010 2018 2002 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Tummino United States 34 2.7k 761 614 562 549 76 4.8k
Edward D. Sturrock South Africa 34 3.0k 1.1× 1.3k 1.7× 691 1.1× 449 0.8× 316 0.6× 128 4.7k
Jules A. Shafer United States 44 2.9k 1.1× 194 0.3× 600 1.0× 329 0.6× 282 0.5× 130 6.0k
Fabrizio Giordanetto Sweden 29 2.7k 1.0× 305 0.4× 524 0.9× 199 0.4× 154 0.3× 73 4.1k
Leszek Wojnowski Germany 39 2.5k 0.9× 589 0.8× 1.8k 3.0× 576 1.0× 231 0.4× 93 6.1k
Rex A. Parker United States 25 1.8k 0.7× 320 0.4× 291 0.5× 353 0.6× 298 0.5× 45 4.0k
Peter Kirkpatrick United States 44 2.7k 1.0× 133 0.2× 1.3k 2.2× 233 0.4× 308 0.6× 146 6.0k
David J. Maloney United States 43 3.3k 1.2× 175 0.2× 905 1.5× 160 0.3× 196 0.4× 140 5.6k
Thomas Ebner Austria 48 1.5k 0.6× 608 0.8× 1.2k 2.0× 268 0.5× 130 0.2× 177 6.9k
Michael A. Patane United States 20 864 0.3× 843 1.1× 168 0.3× 565 1.0× 614 1.1× 39 2.9k
Liang Cao China 44 4.0k 1.5× 164 0.2× 2.1k 3.4× 275 0.5× 454 0.8× 241 8.0k

Countries citing papers authored by Peter J. Tummino

Since Specialization
Citations

This map shows the geographic impact of Peter J. Tummino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Tummino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Tummino more than expected).

Fields of papers citing papers by Peter J. Tummino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Tummino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Tummino. The network helps show where Peter J. Tummino may publish in the future.

Co-authorship network of co-authors of Peter J. Tummino

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Tummino. A scholar is included among the top collaborators of Peter J. Tummino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Tummino. Peter J. Tummino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciccone, David, Scott Boiko, Samantha Carreiro, et al.. (2025). Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 13(7). e012064–e012064.
2.
McElwee, Joshua, Neelu Kaila, Samantha Carreiro, et al.. (2023). Discovery and characterization of novel inhibitors of CTP synthase 1 (CTPS1) for the treatment of autoimmune and inflammatory disease. The Journal of Immunology. 210(Supplement_1). 165.16–165.16. 2 indexed citations
3.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2020). A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. European Journal of Cancer. 138. S20–S20. 1 indexed citations
4.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2020). 685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. SHILAP Revista de lepidopterología. A411.1–A411. 1 indexed citations
5.
Dhanak, Dashyant, et al.. (2017). Small-Molecule Targets in Immuno-Oncology. Cell chemical biology. 24(9). 1148–1160. 43 indexed citations
6.
Ott, Heidi M., Alan P. Graves, Melissa B. Pappalardi, et al.. (2014). A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation. Molecular Cancer Therapeutics. 13(12). 3062–3073. 35 indexed citations
7.
Li, Hua, Benjamin G. Bitler, Vinod Vathipadiekal, et al.. (2011). ALDH1A1 Is a Novel EZH2 Target Gene in Epithelial Ovarian Cancer Identified by Genome-Wide Approaches. Cancer Prevention Research. 5(3). 484–491. 44 indexed citations
8.
Ma, Jianhong, John D. Martin, Yu Xue, et al.. (2010). C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site. Archives of Biochemistry and Biophysics. 503(2). 207–212. 61 indexed citations
9.
Kumar, Rakesh, et al.. (2009). Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors. British Journal of Cancer. 101(10). 1717–1723. 177 indexed citations
10.
Tummino, Peter J. & Robert A. Copeland. (2008). Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function. Biochemistry. 47(32). 8465–8465. 17 indexed citations
11.
Fernandes, Christine, Kang Yan, Hong Zhang, et al.. (2006). A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues. Proceedings of the National Academy of Sciences. 103(20). 7625–7630. 92 indexed citations
12.
Yang, Qing, Peter J. Tummino, Susan Fish, et al.. (2004). Enzymatic Characterization of the Pancreatic Islet-specific Glucose-6-Phosphatase-related Protein (IGRP). Journal of Biological Chemistry. 279(14). 13976–13983. 38 indexed citations
13.
Krosky, Daniel J., Richard A. Alm, Mikael Berg, et al.. (2002). Helicobacter pylori 3-deoxy-D-manno-octulosonate-8-phosphate (KDO-8-P) synthase is a zinc-metalloenzyme. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1594(2). 297–306. 22 indexed citations
14.
Vickers, Chad, Paul Hales, Virendar K. Kaushik, et al.. (2002). Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase. Journal of Biological Chemistry. 277(17). 14838–14843. 1139 indexed citations breakdown →
15.
Ellsworth, Edmund L., John M. Domagala, J. V. N. Vara Prasad, et al.. (1999). 4-Hydroxy-5,6-Dihydro-2H-pyran-2-ones. 3. Bicyclic and hetero-aromatic ring systems as 3-position scaffolds to bind to S1′ and S2′ of the HIV-1 protease enzyme. Bioorganic & Medicinal Chemistry Letters. 9(14). 2019–2024. 8 indexed citations
16.
Prasad, J. V. N. Vara, Larry J. Markoski, John M. Domagala, et al.. (1999). Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moiety. Bioorganic & Medicinal Chemistry Letters. 9(15). 2217–2222. 2 indexed citations
17.
Hagen, Susan E., J. V. N. Vara Prasad, F Boyer, et al.. (1997). Synthesis of 5,6-Dihydro-4-hydroxy-2- pyrones as HIV-1 Protease Inhibitors:  The Profound Effect of Polarity on Antiviral Activity. Journal of Medicinal Chemistry. 40(23). 3707–3711. 47 indexed citations
18.
Prasad, J. V. N. Vara, Kimberly S. Para, Elizabeth A. Lunney, et al.. (1994). Novel Series of Achiral, Low Molecular Weight, and Potent HIV-1 Protease Inhibitors. Journal of the American Chemical Society. 116(15). 6989–6990. 105 indexed citations
19.
Tummino, Peter J., David M. Ferguson, & Donald Hupe. (1994). Competitive Inhibition of HIV-1 Protease by Warfarin Derivatives. Biochemical and Biophysical Research Communications. 201(1). 290–294. 34 indexed citations
20.
Tummino, Peter J. & Ari Gafni. (1991). A comparative study of succinate-supported respiration and ATP/ADP translocation in liver mitochondria from adult and old rats. Mechanisms of Ageing and Development. 59(1-2). 177–188. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026